AZD6244 in Combination With Docetaxel Versus Docetaxel Alone in KRAS Mutation Positive NSCLC Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

88

Participants

Timeline

Start Date

April 20, 2009

Primary Completion Date

May 11, 2011

Study Completion Date

November 2, 2016

Conditions
Non Small Cell Lung Cancer
Interventions
DRUG

AZD6244

oral capsules, 75mg twice daily

DRUG

docetaxel

75mg/m2 iv on day 1 of every 21 day cycle

DRUG

Placebo

placebo

Trial Locations (63)

1032

Research Site, Budapest

1090

Research Site, Brussels

1121

Research Site, Budapest

1122

Research Site, Budapest

1125

Research Site, Budapest

1233

Research Site, Sofia

1527

Research Site, Sofia

1756

Research Site, Sofia

1784

Research Site, Sofia

2045

Research Site, Törökbálint

2650

Research Site, Edegem

3000

Research Site, Leuven

4000

Research Site, Liège

Research Site, Plovdiv

6000

Research Site, Charleroi

7257

Research Site, Mosdós

8000

Research Site, Székesfehérvár

9010

Research Site, Varna

9024

Research Site, Győr

10043

Research Site, Orbassano

13015

Research Site, Marseille

14080

Research Site, México

15006

Research Site, A Coruña

16100

Research Site, Genova

20089

Research Site, Rozzano

20162

Research Site, Milan

21034

Research Site, Dijon

28041

Research Site, Madrid

29010

Research Site, Málaga

29609

Research Site, Brest

35033

Research Site, Rennes

40131

Research Site, Bologna

43210

Research Site, Columbus

58000

Research Site, Morelia

63003

Research Site, Clermont-Ferrand

69373

Research Site, Lyon

80045

Research Site, Aurora

90095

Research Site, Los Angeles

98000

Research Site, Zacatecas City

02115

Research Site, Boston

B-4000

Research Site, Liège

30180-090

Research Site, Belo Horizonte

98700-000

Research Site, Ijuí

90610-000

Research Site, Porto Alegre

20230-130

Research Site, Rio de Janeiro

09060-650

Research Site, Santo André

01221-020

Research Site, São Paulo

04023-062

Research Site, São Paulo

04530-001

Research Site, São Paulo

L1G 2B9

Research Site, Oshawa

K1H 8L6

Research Site, Ottawa

M5G 2M9

Research Site, Toronto

708 52

Research Site, Ostrava

180 81

Research Site, Prague

669 02

Research Site, Znojmo

06132

Research Site, Perugia

00144

Research Site, Roma

LIMA 11

Research Site, Lima

LIMA 27

Research Site, Lima

LIMA 33

Research Site, Lima

LIMA 41

Research Site, Lima

08916

Research Site, Badalona(Barcelona)

08028

Research Site, Barcelona

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY